研究実績
受 賞
論 文
- α1-acid Glycoprotein mitigates MASLD progression by modulating liver and adipose tissue function
Ayano Nishinoiri, Kai Tokumaru, Gai Kanazawa, Yuhi Shintani, Takuma Yoshitake, Takahiro Yamamoto, Soyoka Fukuta, Akiyuki Nishimura, Motohiro Nishida, Toru Takeo, Hitoshi Maeda, Toru Maruyama, Hiroshi Watanabe
Endocrinology. 2026 Jan 8;167(2):bqag009. doi: 10.1210/endocr/bqag009.
- Development of a simple labeling method using fluorescent protein fusion proteins targeting the membrane lipids of small extracellular vesicles
Yuki Kobayashi, Yuki Takahashi, Hiroto Otera, Yuriko Higuchi, Yoshinobu Takakura
J Pharm Biomed Anal.2026 May 15:272:117356. doi: 10.1016/j.jpba.2026.117356.
- Structure-biodistribution relationships of chemically and physically modified albumin: a systematic approach to organ-specific drug delivery Mirai Nakakita, Maichi Hama, Aiko Hashimoto, Mayumi Ikeda-Imafuku, Yasunori Iwao, Victor T G Chuang, Tatsuhiro Ishida, Hiroki Takanari, Yuki Kobayashi, Hitoshi Maeda, Masaki Otagiri, Yu Ishima J Control Release. 2026 Sep 23:115392. doi: 10.1016/j.jconrel.2026.115392.
- Organ Crosstalk in CKD-Associated Frailty: Mechanistic Insights, Translational Opportunities, and Clinical Implications. Hiroshi Watanabe, Yutaka Kitazato, Shu Hirashima, Yuki Enoki, Hiromasa Kato, Wataru Ochiai, Hitoshi Maeda, Motoko Tanaka, Kazutaka Matsushita, Toru Maruyama Biol Pharm Bull. 2026;49(6):896-909. doi: 10.1248/bpb.b26-00057.
- Albumin as a dynamic extracellular redox regulator: from Cys34 oxidation biomarkers to polysulfide-mediated homeostatic mechanisms and clinical applications. Yu Ishima, Hiroshi Watanabe, Mayumi Ikeda-Imafuku, Hitoshi Maeda, Toru Maruyama, Masaki Otagiri, Victor T G Chuang Redox Rep. 2026 Dec 31;31(1):2682043. doi: 10.1080/13510002.2026.2682043.
- Tumor-derived Parathyroid Hormone-Related Protein Is Associated with Suppression of Cytochrome P450 Expression: Evidence From Multimodal Transcriptomics. Issei Fujita, Tsubasa Kaji, Isamu Noguchi, Kai Tokumaru, Hitoshi Maeda, Toru Maruyama, Hiroshi Watanabe ACS Pharmacol Transl Sci. 2026 Jun 22;9(8):2234-2249. doi: 10.1021/acsptsci.6c00079.
学会発表等
- アルブミンとSPARCの相互作用を利用した損傷筋指向型DDSの開発とサルコペニア治療への応用
前田 仁志
第3回日本運動分子生物学研究会 2026年1月
講演等
その他
補遺
